Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

08:56
10/10/16
10/10
08:56
10/10/16
08:56

Mylan gaps up sharply in pre-market after reaching deal with DOJ

The shares are up over 12% to $40.29 at time of writing. At that price next resistance is at $41.37. Support is at $39.20.

  • 09

    Nov

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

10/10/16
UBSW
10/10/16
NO CHANGE
Target $60
UBSW
Buy
UBS remains constructive on Mylan despite governance controversy
UBS analyst Marc Goodman said he remains constructive on Mylan despite the controversy surrounding its corporate governance. Goodman cited the company's ability to execute, its surprise announcement of a EpiPen Medicaid lawsuit settlement and its updated guidance, which was better than feared. Goodman reiterated his Buy rating and lowered his price target to $60 from $66 on Mylan shares.
10/10/16
RAJA
10/10/16
UPGRADE
Target $57
RAJA
Strong Buy
Mylan upgraded to Strong Buy on EpiPen settlement at Raymond James
As previously reported, Raymond James upgraded Mylan two notches to Strong Buy from Market Perform and established a $57 price target. Analyst Elliot WIlbur said the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. With depressed absolute and relative valuation levels, Wilber sees favorable risk/reward scenarios even in a more tempered earnings growth environment.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan settlement, updated guidance a positive, says JPMorgan
JPMorgan analyst Chris Schott views Mylan's $465M settlement with the Department of Justice relating to the potential misclassification of Epipen in the Medicaid Drug Rebate Program as well as its updated 2016 guidance as a positive. The news "removes litigation overhang at a reasonable cost and highlights the diversification of the base business and inexpensive valuation," Schott tells investors in a research note. He keeps an Overweight rating on Mylan with a $52 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Mylan settlement does not end EpiPen issue, says Wells Fargo
In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.

TODAY'S FREE FLY STORIES

CPRT

Copart

$60.30

1.29 (2.19%)

18:09
02/21/17
02/21
18:09
02/21/17
18:09
Earnings
Copart reports Q2 adjusted EPS 58c, consensus 57c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

DAL

Delta Air Lines

$51.21

-0.02 (-0.04%)

18:07
02/21/17
02/21
18:07
02/21/17
18:07
Hot Stocks
Aeromexico says concludes Delta tender offer 'represents fair value' »

Grupo Aeromexico issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSS

Golden Star Resources

$0.99

0.0232 (2.40%)

18:04
02/21/17
02/21
18:04
02/21/17
18:04
Hot Stocks
Golden Star Resources sees FY17 gold production 255,000-280,000 »

Sees FY17 AISC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GSS

Golden Star Resources

$0.99

0.0232 (2.40%)

17:57
02/21/17
02/21
17:57
02/21/17
17:57
Earnings
Golden Star Resources reports Q4 adjusted EPS 1c, consensus (1c) »

Reports Q4 gold revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CY

Cypress Semiconductor

$13.12

0.22 (1.71%)

17:52
02/21/17
02/21
17:52
02/21/17
17:52
Hot Stocks
Cypress Semiconductor founder nominates two candidates for board »

T.J. Rodgers, founder and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 16

    Mar

XPO

XPO Logistics

$48.38

-0.84 (-1.71%)

, DEPO

Depomed

$15.77

-0.7 (-4.25%)

17:41
02/21/17
02/21
17:41
02/21/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: XPO…

XPO

XPO Logistics

$48.38

-0.84 (-1.71%)

DEPO

Depomed

$15.77

-0.7 (-4.25%)

WMGI

Wright Medical

$26.86

-0.1 (-0.37%)

HCLP

Hi-Crush Partners

$21.40

0.1 (0.47%)

RRGB

Red Robin

$47.50

-0.3 (-0.63%)

FSLR

First Solar

$36.62

1.78 (5.11%)

LNTH

Lantheus

$9.35

-0.1 (-1.06%)

GE

General Electric

$30.52

0.15 (0.49%)

TRCO

Tribune Media

$33.70

0.73 (2.21%)

SREV

ServiceSource

$6.05

0.22 (3.77%)

FUEL

Rocket Fuel

$2.55

0.08 (3.24%)

TXRH

Texas Roadhouse

$47.79

-0.45 (-0.93%)

WLL

Whiting Petroleum

$11.57

0.46 (4.14%)

TEX

Terex

$32.13

0.13 (0.41%)

PZZA

Papa John's

$85.63

-0.38 (-0.44%)

FE

FirstEnergy

$31.33

0.32 (1.03%)

PKD

Parker Drilling

GBT

Global Blood Therapeutics

$28.50

1.6 (5.95%)

CUZ

Cousins Properties

$8.66

0.01 (0.12%)

YUM

Yum! Brands

$67.67

-0.73 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 07

    Mar

  • 07

    Mar

  • 14

    Mar

  • 26

    Apr

  • 09

    May

  • 22

    Feb

GLA

GlassBridge

, IMN

Imation

$0.77

-0.0091 (-1.17%)

17:41
02/21/17
02/21
17:41
02/21/17
17:41
Hot Stocks
GlassBridge implements name change, reverse stock split »

GlassBridge Enterprises…

GLA

GlassBridge

IMN

Imation

$0.77

-0.0091 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HVT

Haverty Furniture

$22.95

0.4 (1.77%)

17:37
02/21/17
02/21
17:37
02/21/17
17:37
Earnings
Haverty Furniture reports Q4 EPS 51c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CUZ

Cousins Properties

$8.66

0.01 (0.12%)

17:36
02/21/17
02/21
17:36
02/21/17
17:36
Syndicate
Breaking Syndicate news story on Cousins Properties »

Cousins announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

CUZ

Cousins Properties

$8.66

0.01 (0.12%)

17:36
02/21/17
02/21
17:36
02/21/17
17:36
Syndicate
Cousins announces offering of 25M shares of common stock »

Cousins Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

VMI

Valmont

$143.80

0.4 (0.28%)

17:35
02/21/17
02/21
17:35
02/21/17
17:35
Hot Stocks
Valmont expects EPS to decrease on GAAP basis »

The company said "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

VMI

Valmont

$143.80

0.4 (0.28%)

17:34
02/21/17
02/21
17:34
02/21/17
17:34
Earnings
Valmont sees FY17 adjusted EPS $6.42, consensus $6.78 »

Sees FY17 revenue up -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

VMI

Valmont

$143.80

0.4 (0.28%)

17:32
02/21/17
02/21
17:32
02/21/17
17:32
Earnings
Valmont reports Q4 adjusted EPS $1.61, consensus $1.45 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GNMX

Aevi Genomics Medicine

$5.09

0.18 (3.67%)

17:31
02/21/17
02/21
17:31
02/21/17
17:31
Hot Stocks
Aevi Genomics Medicine announces expansion of collaboration with CHOP »

Aevi Genomic Medicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 21

    Mar

UNH

UnitedHealth

$160.57

2.95 (1.87%)

, SCAI

Surgical Care Affiliates

$56.59

-0.1 (-0.18%)

17:29
02/21/17
02/21
17:29
02/21/17
17:29
Hot Stocks
UnitedHealth commences exchange offer to acquire Surgical Care Affiliates »

UnitedHealth (UNH)…

UNH

UnitedHealth

$160.57

2.95 (1.87%)

SCAI

Surgical Care Affiliates

$56.59

-0.1 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNI

Silver Spring

$14.04

0.36 (2.63%)

17:28
02/21/17
02/21
17:28
02/21/17
17:28
Earnings
Silver Spring sees Q1 revenue $45M-$50M, may not compare to consensus $75.29M »

Sees Q1 billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNI

Silver Spring

$14.04

0.36 (2.63%)

17:27
02/21/17
02/21
17:27
02/21/17
17:27
Earnings
Silver Spring sees FY17 revenue $400M-$420M, consensus $331.01M »

Sees FY17 billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$78.17

-1.33 (-1.67%)

17:25
02/21/17
02/21
17:25
02/21/17
17:25
Hot Stocks
Macquarie Infrastructure sees 10% dividend growth in 2017 »

"We are also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

MIC

Macquarie Infrastructure

$78.17

-1.33 (-1.67%)

17:24
02/21/17
02/21
17:24
02/21/17
17:24
Hot Stocks
Macquarie Infrastructure raises quarterly dividend to $1.31 per share »

The MIC board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

SPN

Superior Energy

$16.62

0.2 (1.22%)

17:20
02/21/17
02/21
17:20
02/21/17
17:20
Earnings
Superior Energy reports Q4 EPS (74c), consensus (77c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TOL

Toll Brothers

$31.99

0.5 (1.59%)

17:18
02/21/17
02/21
17:18
02/21/17
17:18
Hot Stocks
Toll Brothers announces initiation of cash dividend »

Toll Brothers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

LAND

Gladstone Land

$12.49

0.24 (1.96%)

17:17
02/21/17
02/21
17:17
02/21/17
17:17
Earnings
Gladstone Land reports Q4 FFO 13.6c vs. 13.5c last quarter »

Reports Q4 revenue $4.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

HLS

HealthSouth

$42.93

0.93 (2.21%)

17:16
02/21/17
02/21
17:16
02/21/17
17:16
Earnings
HealthSouth reports Q4 adjusted EPS 72c, consensus 62c »

Reports Q4 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

  • 05

    Mar

SHO

Sunstone Hotel

$15.20

0.07 (0.46%)

17:13
02/21/17
02/21
17:13
02/21/17
17:13
Hot Stocks
Sunstone Hotel approves $300M increase to share repurchase program »

On February 17 the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SHO

Sunstone Hotel

$15.20

0.07 (0.46%)

17:11
02/21/17
02/21
17:11
02/21/17
17:11
Hot Stocks
Sunstone Hotel expects to pay a regular dividend of 5c per share throughout 2017 »

The Company expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.